Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels

Clinical trial NCT06284850 · UNKNOWN

Trial details

NCT number: NCT06284850
Sponsor: Aristotle University Of Thessaloniki
Status: UNKNOWN
Study type: OBSERVATIONAL

Hematocrit Change Cardiovascular Prevention Empagliflozin SGLT2-Inhibitors Tissue Oxygenation

Start date: 2023-11-30
Primary completion: 2025-11-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.